Capital Raising Through Third-Party Allotment
First written in FY2016. 31 of 36 entries say "Advanced", first in FY2016. Latest entry: 2026-08-14.
42 other companies' latest entry also says "Advanced".
- 2026-08-14AdvancedOccurring Fact
「第15回新株予約権の行使により資本金及び資本準備金がそれぞれ60,750千円増加しております。」
第15回新株予約権の行使による資本金及び資本準備金の増加を計上した。 - FY2026AdvancedAnnual report
「1 April 2025–31 March 2026 242,930,000 541,556,993 2,070,978 7,831,753 2,070,978 7,696,740」
The exercise of Series 14 stock acquisition rights resulted in the issuance of 242,930,000 shares during the current period and increases of ¥2,070.978 million each in stated capital and the capital reserve. - FY2026-H1AdvancedAnnual report
「1 April 2025–30 September 2025 (Note 1) 242,930,000 541,556,993 2,070,978 7,831,753 2,070,978 7,696,740 25 July 2025 (Note 2) 6,134,000 547,690,993 190,154 8,021,907 190,154 7,886,894」
The exercise of Series 14 stock acquisition rights resulted in the issuance of 242,930,000 shares and increases of ¥2,070.978 million each in stated capital and the capital reserve. In addition, 6,134,000 restricted stock compensation shares were issued. - FY2025AdvancedAnnual report
「1 April 2024–31 March 2025 157,070,000 298,626,993 1,339,022 5,760,775 1,339,022 5,625,762 (Note 9) Increase resulting from the exercise of stock acquisition rights.」
The exercise of Series 14 stock acquisition rights resulted in the issuance of 157,070,000 shares during the current period and increases of ¥1,339 million each in stated capital and the capital reserve. Financing activities raised ¥2,670 million through the issuance of shares. - FY2025-H1AdvancedAnnual report
「1 April 2024–30 September 2024 70,300,000 211,856,993 599,307 5,021,061 599,307 4,886,048 (Note) Increase resulting from the exercise of stock acquisition rights.」
The exercise of Series 14 stock acquisition rights resulted in the issuance of 70.3 million shares during the six-month period and increases of ¥599.307 million each in stated capital and the capital reserve. - FY2024RaisedAnnual report
「Class, description and number of shares underlying the stock acquisition rights (shares) Common shares: 400,000,000 shares [399,500,000 shares] Payment amount upon exercise of stock acquisition rights (yen) ¥17 per share (fixed) Exercise period for stock acquisition rights 30 May 2024 to 29 May 2026 Issue price ¥6,800,000,000」
After the filing date, the company issued Series 14 stock acquisition rights through a third-party allotment, setting a maximum of 400 million shares, an issue price of ¥6.8 billion and an exercise period ending 29 May 2026. The scale of capital raising and the number of potential shares have increased substantially. - FY2024-Q3AdvancedAnnual report
「1 October 2023–31 December 2023 268,900 141,556,993 3,630 4,421,698 3,630 4,286,685 (Note) Increase resulting from the exercise of stock acquisition rights.」
The filing states that during the third quarter of the current accounting period, total shares issued increased by 268,900 and stated capital and the capital reserve each increased by ¥3.63 million. - FY2024-Q2AdvancedAnnual report
「The exercise of Series 13 stock acquisition rights and the conversion of Series 3 unsecured convertible bonds with stock acquisition rights each increased stated capital and the capital reserve by ¥38.75 million. As a result, at the end of the second quarter of the current consolidated accounting period, stated capital was ¥4,418.068 million and capital surplus was ¥4,372.896 million.」
The exercise of Series 13 stock acquisition rights and the conversion of convertible bond-type bonds with stock acquisition rights each increased stated capital and the capital reserve by ¥38.75 million, advancing capital raising. - FY2024-Q1AdvancedAnnual report
「Number of bonds with stock acquisition rights, etc., with an adjustment clause for the exercise price exercised during the first quarter of the current accounting period 25,000 Number of shares delivered in connection with exercises during the current quarterly accounting period 2,500,000 Funds raised through exercises during the current quarterly accounting period (¥ thousands) 67,500 Number of bonds with stock acquisition rights, etc., with an adjustment clause for the exercise price exercised during the first quarter of the current accounting period 1 Number of shares delivered in connection with exercises during the current quarterly accounting period 555,555」
The exercise of Series 13 stock acquisition rights raised ¥67.5 million through the issuance of 2.5 million shares, while the conversion of Series 3 unsecured convertible bonds with stock acquisition rights resulted in the delivery of 555,555 shares. Capital raising also progressed during the quarter. - FY2023AdvancedAnnual report
「During the consolidated fiscal year, increases of 21,296,294 shares from the conversion of convertible bond-type bonds with stock acquisition rights and 6,886,400 shares from the exercise of stock acquisition rights occurred.」
During the current period, the company issued 6,886,400 shares through the exercise of stock acquisition rights and 21,296,294 shares through the conversion of convertible bond-type bonds with stock acquisition rights, advancing its capital raising. - FY2023-Q3AdvancedAnnual report
「During the third quarter accounting period, the stock acquisition rights related to bonds with stock acquisition rights subject to conditions for revising the exercise price were exercised as follows.」
The conversion of convertible bond-type bonds with stock acquisition rights resulted in the delivery of 3,888,888 shares and proceeds of ¥70 million during the quarter. Cumulatively, 4,629,628 shares had been delivered and ¥90 million had been raised, indicating further progress in capital raising. - FY2023-Q2AdvancedAnnual report
「1 July 2022–30 September 2022 (Note 1) 4,826,400 117,676,984 70,972 4,194,318 70,972 4,059,305 (Note 1) Increase resulting from the exercise of stock acquisition rights.」
The exercise of Series 12 stock acquisition rights and other rights resulted in the issuance of 4,826,400 shares during the quarter and increases of ¥70.972 million each in stated capital and the capital reserve. By the filing date, a further 3,888,888 shares had been issued through the conversion of convertible bond-type bonds with stock acquisition rights. - FY2023-Q1AdvancedAnnual report
「During the first 3 months of the current consolidated accounting period, the exercise of stock acquisition rights issued during the period and the conversion of convertible bond-type bonds with stock acquisition rights each increased stated capital and the capital reserve by ¥40.292 million.」
The newly issued stock acquisition rights were exercised and the convertible bond-type bonds with stock acquisition rights were converted, increasing stated capital and the capital reserve by ¥40.292 million each. - FY2022-Q3Change in the Use of FundsAnnual report
「Following the settlement reached with Tact Home Co., Ltd., payment of a ¥536 million settlement amount was confirmed and an obligation to pay by April 2025 arose. Accordingly, the use of proceeds from the exercise of the Series 12 stock acquisition rights issued by the company was changed so that part of the proceeds would be allocated to the settlement payment.」
The use of proceeds from the exercise of Series 12 stock acquisition rights was changed so that, in addition to working capital for the crowdfunding business and existing businesses, part would be allocated to funding the ¥536 million settlement payment arising from the settlement. - FY2022-Q2AdvancedAnnual report
「Number of bonds with stock acquisition rights, etc., with an adjustment clause for the exercise price exercised during the current quarterly accounting period (units): 76,550 Number of shares delivered in connection with exercises during the current quarterly accounting period (shares): 7,655,000 Funds raised through exercises during the current quarterly accounting period (¥ thousands): 235,118 Cumulative number of shares delivered in connection with these bonds with stock acquisition rights, etc., as of the end of the current quarterly accounting period (shares): 16,405,000 Cumulative funds raised through these bonds with stock acquisition rights, etc., as of the end of the current quarterly accounting period (¥ thousands): 555,968」
The exercise of Series 12 stock acquisition rights resulted in the issuance of 7,655,000 shares and proceeds of ¥235.118 million during the quarter. Cumulatively, 16,405,000 shares had been delivered and ¥555.968 million had been raised. - FY2022-Q1AdvancedAnnual report
「During the first 3 months of the current consolidated accounting period, the issuance of new shares and exercise of stock acquisition rights increased stated capital and the capital reserve by ¥262.219 million each.」
The issuance of new shares and exercise of stock acquisition rights were completed, increasing stated capital and the capital reserve by ¥262.219 million each. - FY2021RaisedAnnual report
「On 30 April 2021, the company resolved to issue new shares and Series 12 stock acquisition rights with an adjustment clause for the exercise price through a third-party allotment. It will raise ¥200 million through the issuance of new shares and ¥2,014 million through the issuance of stock acquisition rights.」
Following the filing date, the company plans a substantial capital raising through a third-party allotment, consisting of ¥200 million in new shares and ¥2,014 million in stock acquisition rights. - FY2021-Q3AdvancedAnnual report
「1 October 2020–31 December 2020 1,000,000 72,013,244 35,500 3,380,546 35,500 3,245,533 (Note) Increase resulting from the exercise of Series 11 stock acquisition rights.」
The exercise of Series 11 stock acquisition rights resulted in the issuance of 1 million shares during the quarter and increases of ¥35.5 million each in stated capital and the capital reserve. - FY2021-Q2AdvancedAnnual report
「1 July 2020–30 September 2020 3,000,000 71,013,244 106,500 3,345,046 106,500 3,210,033 (Note) Increase resulting from the exercise of Series 11 stock acquisition rights.」
The exercise of Series 11 stock acquisition rights resulted in the issuance of 3,000,000 shares during the quarter and increases of ¥106.5 million each in stated capital and the capital reserve. Total shares issued increased to 71,013,244. - FY2021-Q1AdvancedAnnual report
「During the first quarter of the current consolidated accounting period, stated capital and the capital reserve each increased by ¥53.25 million in connection with the exercise of stock acquisition rights issued in the previous fiscal year. In addition, some of the Series 11 stock acquisition rights were exercised between the end of the period and the filing date of the quarterly report. The details are as follows. (1) Class and number of shares issued: common shares, 3,000,000 shares」
During the quarter, the exercise of Series 11 stock acquisition rights increased stated capital and the capital reserve by ¥53.25 million each, and an additional 3 million common shares were issued by the filing date. - FY2020AdvancedAnnual report
「This was mainly due to proceeds of ¥629 million from the issuance of new shares in the current period, ¥11 million from the issuance of stock acquisition rights and ¥528 million from short-term borrowings, among other factors.」
During the current period, 10,000,000 new shares were issued through a third-party allotment and 500,000 shares were issued through the exercise of stock acquisition rights, resulting in ¥932 million of cash inflows from financing activities. - FY2020-Q3AdvancedAnnual report
「At an extraordinary meeting of the Board of Directors held on 27 December 2019, the company resolved to issue shares through a third-party allotment at a particularly favorable payment amount, and payment was completed on 21 January 2020. The details are as follows. 1. Class of shares offered Common shares 2. Number of shares offered 10,000,000 shares 4. Total payment amount ¥700,000,000」
Payment was completed for 10 million common shares issued through a third-party allotment, for a total of ¥700 million. Payment was also completed for 114,300 Series 11 stock acquisition rights, representing 11.43 million potential shares. - FY2019-Q2AdvancedAnnual report
「During the first six months of the current consolidated accounting period, proceeds from the exercise of stock acquisition rights issued in the previous fiscal year amounted to ¥142 million. In addition, 1,210,000 common shares were issued through the exercise of stock acquisition rights between 1 July 2018 and 30 September 2018, increasing stated capital and the capital reserve by ¥42.108 million each.」
The company raised ¥142 million through the exercise of stock acquisition rights, issued 1,210,000 shares during the quarter, and increased stated capital and the capital reserve by ¥42.108 million each. - FY2019-Q1AdvancedAnnual report
「During the first quarter of the current consolidated accounting period, stated capital and the capital reserve each increased by ¥29.58 million in connection with the exercise of stock acquisition rights issued in the previous fiscal year.」
The exercise of stock acquisition rights issued in the previous fiscal year continued during the quarter, increasing stated capital and the capital reserve by ¥29.58 million each. - FY2018AdvancedAnnual report
「Funds provided by financing activities during the current consolidated fiscal year amounted to ¥1,431 million, compared with proceeds of ¥1,382 million in the previous consolidated fiscal year. The main factor was proceeds of ¥1,460 million from the exercise of stock acquisition rights issued in the previous period and the issuance of new shares through a third-party allotment conducted in March 2018.」
In addition to the exercise of stock acquisition rights issued in the previous fiscal year, the company carried out a capital increase by third-party allotment in March 2018 and received ¥1,460 million in proceeds. - FY2018-Q3RestatedAnnual report
「During the first 9 months of the current consolidated accounting period, stated capital and the capital reserve each increased by ¥494.04 million in connection with the exercise of stock acquisition rights issued in the previous fiscal year.」
The company continues to report an increase of ¥494.04 million each in stated capital and the capital reserve from the exercise of stock acquisition rights issued in the previous fiscal year, but no new increase is shown. - FY2018-Q2AdvancedAnnual report
「During the first six months of the current consolidated accounting period, stated capital and the capital reserve each increased by ¥494.04 million in connection with the exercise of stock acquisition rights issued in the previous fiscal year.」
The exercise of stock acquisition rights progressed, resulting in cumulative increases of ¥494.04 million each in stated capital and the capital reserve. The second quarter also included an increase resulting from the issuance of 10,000,000 shares. - FY2018-Q1AdvancedAnnual report
「During the first quarter of the current consolidated accounting period, stated capital and the capital reserve each increased by ¥136.04 million in connection with the exercise of stock acquisition rights issued in the previous fiscal year. In addition, some of the Series 8 stock acquisition rights were exercised between the end of the period and the filing date of the quarterly report. The details are as follows: (1) Class and number of shares issued: common shares, 9,200,000 shares (2) Increase in stated capital: ¥330 million (3) Increase in capital surplus: ¥330 million」
During the quarter, the exercise of Series 8 stock acquisition rights increased stated capital and the capital reserve by ¥136.04 million each. By the filing date, a further 9,200,000 common shares had been issued, and stated capital and capital surplus had each increased by ¥330 million. - FY2017-Q3AdvancedAnnual report
「In addition, stated capital and the capital reserve increased by ¥430.5 million in connection with the payment for new shares issued through a third-party allotment approved on 10 November 2016. Stated capital and the capital reserve also each increased by ¥103.82 million in connection with the exercise of stock acquisition rights approved for issuance at the same time.」
The payment for the new shares in the new capital increase by third-party allotment and the exercise of stock acquisition rights were completed, resulting in specific increases in stated capital and the capital reserve. - FY2017-Q2AdvancedAnnual report
「At an extraordinary meeting of the Board of Directors held on 24 October 2016, the company resolved to issue shares through a third-party allotment at a particularly favorable payment amount. At the extraordinary general meeting of shareholders, the proposal concerning the issuance of these shares was approved as originally proposed. (1) Number of shares offered: 15,500,000 shares (2) Total payment amount for the shares offered: ¥1,085,000,000 (6) Payment date: 18 November 2016」
In addition to the progress made on the payment for new shares issued through the previous third-party allotment and the exercise of stock acquisition rights, a new capital increase by third-party allotment of 15,500,000 shares for a total of ¥1,085,000,000 was approved and resolved. - FY2017-Q1AdvancedAnnual report
「During the first quarter of the current consolidated accounting period, stated capital and the capital reserve increased by ¥220.5 million in connection with the payment for new shares issued through a third-party allotment approved on 13 May 2016. In addition, stated capital and the capital reserve each increased by ¥31.83 million in connection with the exercise of stock acquisition rights approved for issuance at the same time.」
The payment for new shares issued through a third-party allotment and the exercise of stock acquisition rights were completed, resulting in specific increases in stated capital and the capital reserve. - FY2016AdvancedAnnual report
「Through a paid-in capital increase by third-party allotment with 30 May 2016 as the payment date, the number of shares issued increased by 2,100,000, while stated capital and the capital reserve each increased by ¥110.25 million.」
After the filing, the company conducted a capital increase by third-party allotment, resulting in specific increases in the number of shares, stated capital and the capital reserve.